IP Library Patent Application 17147200
Patent Application
App. No. 17/147,200

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/147,200
Abstract

An aqueous liquid suspension containing a coated drug—ion exchange resin complex comprising a core composed of an amphetamine complexed with a pharmaceutically acceptable ion-exchange resin and an uncoated amphetamine—ion exchange resin complex is provided. The coated amphetamine—ion exchange resin complex is in admixture with a polymer to form a matrix. Methods of making the coated complex and the liquid suspension are described.

Claims (2)

1 . A modified release coated drug—ion exchange resin complex useful in preparing modified release pharmaceutical composition, said complex comprising a drug bound to a pharmaceutically acceptable ion exchange resin and having a high tensile strength water-permeable, water-insoluble, modified release polymeric barrier coating over the drug—ion exchange resin complex.

2 . A method of treating a patient in need thereof with a pharmaceutically active drug having a modified release profile, said method comprising orally delivering a composition according to claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2021
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC.
Reel/Frame 055893/0122 →